Long Ideas - In the next several weeks, Keryx Biopharmaceuticals (KERX) will release results from 4 key Phase III trials for its primary drug candidate, Zerenex. The drug … Continue Reading
Read nowMost Popular - We offered some insight this week into how social media can drive the markets. Jason Napodano noted recent performance from SRPT, and discussed what patient-investor … Continue Reading
Read nowQuick Picks - After declines in the first half of the week, shares of Threshold Pharmaceuticals (NASDAQ:THLD) rebounded on Thursday morning following an update on the company’s ongoing … Continue Reading
Read nowMost Popular - Thursday morning, Israeli financial newspaper, Calcalist is reporting that Teva Pharmaceuticals (NASDAQ:TEVA) and AstraZeneca (NYSE:AZN) are leading candidates among other large drug companies interested in … Continue Reading
Read nowLong Ideas - Puma Biotechnology (NYSE:PBYI) made waves last month when it uplisted to the NYSE and initiated a substantial capital raise, increasing cash and equivalents to approximately … Continue Reading
Read nowLong Ideas - The biotechnology sector is one where growth is, for the most part, fueled by a single factor: new drugs. Companies that develop the next generation … Continue Reading
Read nowLong Ideas - Endocyte (NASDAQ:ECYT) recently confirmed that the Marketing Authorization Application (MAA) filing process for vintafolide and etarfolatide in Europe is set to be completed by the end … Continue Reading
Read now